Schedule 13G ownership disclosure
ArriVent Biopharma Inc
Security class unavailable · CUSIP: 04272N102
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-24-017477
- Form type
- SC 13G
- Filer
- ArriVent BioPharma, Inc.
- CIK
- CIK 1868279
- Filed
- Oct 11, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership